Clinical Research Directory
Browse clinical research sites, groups, and studies.
Nexus Evaluation Primary Trident II Uncemented Shell
Sponsor: NHS Lothian
Summary
This is a prospective cohort study assessing the survival of a new acetabula component which is based on the original Trident acetabular system (cementless shell) which is used for Total Hip Arthroplasty. The manufacturer recently introduced the evolution of this product, the Trident® II acetabular shell which was launched in 2017. This implant is CE marked and is now widely available for the UK market, however has minimal clinical outcomes data to support its use. As part of a stepwise introduction of devices to orthopaedic practice. This study will report the 10 year implant survival and patient functional outcomes of this new implant.
Official title: Nexus Evaluation Primary Trident II UNcemented shEll (NEPTUNE): A Longitudinal Cohort Study of the Hydroxyapatite Coated Trident II Acetabular System in Total Hip Arthroplasty
Key Details
Gender
All
Age Range
18 Years - 75 Years
Study Type
INTERVENTIONAL
Enrollment
125
Start Date
2022-06-01
Completion Date
2034-11-25
Last Updated
2026-02-13
Healthy Volunteers
No
Interventions
Stryker Trident® II HA coated cementless acetabula component
New acetabula component.
Locations (1)
NHS Lothian
Edinburgh, Lothian, United Kingdom